Advertisement
  1. Home
  2. Topics
  3. Astrazeneca

Topic - Astrazeneca

Related Stories

In this Jan. 21, 2021, file photo a medical staff member prepares the Pfizer COVID-19 vaccine at Tudor Ranch in Mecca, Calif. With vaccination against COVID-19 in full swing, social platforms like Facebook, Instagram and Twitter say they’ve stepped up their fight against misinformation that aims to undermine trust in the vaccines. (AP Photo/Jae C. Hong, File)

‘Twitter Files’: Big Pharma pressured platform to censor COVID-19 vaccine debate

FILE - Syringes and colorful bandages are prepared as children from local schools prepare to get COVID-19 vaccines in Pittsfield, Mass., on Monday Dec. 13, 2021. A review by federal health officials finds that Pfizer's COVID-19 vaccine appears safe and effective for children under 5, the only group not currently eligible for vaccination. The review issued Sunday, June 12, 2022, by the Food and Drug Administration is a key step toward a decision on vaccinations for babies, toddlers and preschoolers, perhaps as soon as June 21. (Ben Garver/The Berkshire Eagle via AP, File)

Pfizer, BioNTech now siccing experimental COVID shots on babies

FILE - A general view of AstraZeneca offices and the corporate logo in Cambridge, England, Saturday, July 18, 2020. AstraZeneca has recorded a big jump in revenue as it begins to take a profit from its coronavirus vaccine for the first time. The company recorded full-year revenues of $37.4 billion, an increase of 38% from the year before at constant exchange rates. Part of the boost came from $4 billion in sales of its COVID-19 vaccine, developed with the University of Oxford. Despite rising revenue, AstraZeneca reported a pre-tax loss of $265 million due to costs from its purchase of U.S. drug company Alexion Pharmaceuticals and new drug research. (AP Photo/Alastair Grant, File)

COVID-19 nasal spray fails in trial by Oxford University and AstraZeneca

FILE - Professor Dame Sarah Gilbert on June 11, 2021. In excerpts released ahead of a speech Monday Dec. 6, 2021, Prof. Sarah Gilbert, one of the scientists behind the Oxford-AstraZeneca COVID-19 vaccine, is warning that the next pandemic may more contagious and more lethal unless more money is devoted to research and preparations to fight emerging viral threats. (Steve Parsons/PA via AP, file)

Big Pharma, WHO, globalists tee up next virus fear

The French vaccine startup Valneva headquarters is pictured in Saint-Herblain, western France, Wednesday, Feb. 3, 2021. French pharmaceutical startup Valneva had big news in September: a government contract for 60 million doses of its coronavirus vaccine candidate. The buyer? The United Kingdom — not the European Union, as might be expected for a company on the banks of the Loire. (AP Photo/David Vincent)

French drugmaker Valneva reports positive COVID-19 vaccine results

Eric Clapton, center, performs during his "70th Birthday Celebration" concert at Madison Square Garden on Friday, May 1, 2015, in New York. (Luiz C. Ribeiro/Invision/AP) ** FILE **

Eric Clapton plays arena with COVID-19 vaccine requirement, despite anti-mandate stance

FILE - In this April 8, 2021 file photo, the Johnson & Johnson COVID-19 vaccine is seen at a pop up vaccination site in the Staten Island borough of New York. The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine bulk substance to resume, the company said Thursday, July 29. The Baltimore factory was shut down by the FDA in mid-April due to contamination problems that forced the company to trash the equivalent of tens of millions of doses of vaccine it was making under contract for Johnson & Johnson. (AP Photo/Mary Altaffer, File)

Emergent: FDA letting troubled COVID vaccine factory restart

House Oversight and Reform Committee Chairwoman Carolyn Maloney, D-N.Y., speaks during a House Oversight and Reform Committee regarding the on Jan. 6 attack on the U.S. Capitol, on Capitol Hill in Washington, Wednesday, May 12, 2021. (Jonathan Ernst/Pool via AP) **FILE**

House report: Top drugmakers spend more on investor perks than R&D

Jens Spahn (CDU), Germany's Federal Minister of Health, comments at a press conference on the consequences of the STIKO recommendation to administer an mRNA vaccine after a first vaccination with Astrazeneca in Berlin, Germany, Friday, July 2, 2021. (Fabian Sommer/dpa via AP)

Germany recommends combination of AstraZeneca, mRNA shots

Lawyers for the European Commission, left, and AstraZeneca right, prepare arguments during a hearing, European Commission vs AstraZeneca, at the main courthouse in Brussels, Wednesday, May 26, 2021. (AP Photo/Virginia Mayo)

EU takes on AstraZeneca in court over COVID-19 vaccine deliveries

In this March 22, 2021, file photo, vials of the AstraZeneca COVID-19 vaccine sit in a fridge at the local vaccine center in Ebersberg near Munich, Germany. The European Commission will try this week to persuade a Belgian court to order the AstraZeneca pharmaceutical company to deliver millions of doses of its COVID-19 vaccines to EU countries. The EU accuses the Anglo-Swedish drugmaker of failing to deliver the number of shots it agreed. AstraZenecas contract signed with the Commission on behalf of all 27 EU member states foresaw an initial 300 million doses for distribution among member countries, with an option for a further 100 million. The doses were expected to be delivered throughout 2021 but only 30 million were sent during the first quarter. (AP Photo/Matthias Schrader, File)

AstraZeneca vaccine linked to 3 strokes

In this Monday, March 9, 2020, file photo, Tedros Adhanom Ghebreyesus, director-general of the World Health Organization, speaks during a news conference, at the WHO headquarters in Geneva, Switzerland. (Salvatore Di Nolfi/Keystone via AP, File)

WHO chief: We must vaccinate 10% of the global population by September, 30% by December

Japanese Health Minister Norihisa Tamura, center, speaks to reporters in Tokyo Thursday night, May 20, 2021, after a health ministry panel approved two new COVID-19 vaccines. Japan has approved the usage of Moderna and AstraZeneca vaccines and is set to expand the state of emergency target Friday, in its latest efforts to contain a surge of coronavirus infections nine weeks ahead of the opening of the Tokyo Olympics. (Shohei Miyano/Kyodo News via AP)

Japan approves Moderna, AstraZeneca COVID-19 vaccines

Robert Kramer, president and chief executive officer of Emergent BioSolutions, speaks via videoconference during a House Select Subcommittee on the Coronavirus Crisis hearing on Capitol Hill in Washington, Wednesday, May 19, 2021, examining Emergent BioSolutions, a Maryland biotech firm whose Baltimore plant ruined millions of doses of the coronavirus vaccine. (Stefani Reynolds/The New York Times via AP, Pool)

Emergent BioSolutions CEO: We take ‘full responsibility’ for vaccine mishap

In this Feb. 24, 2021, file photo, a medical worker holds up a vial of the Sputnik V coronavirus vaccine, as the city health department conducts a mass vaccination campaign for Mexicans over age 60, at Palacio de los Deportes in Mexico City. Mexico will begin bottling and packaging the Russian vaccine, Mexico Foreign Affairs Secretary Marcelo Ebrard said Wednesday, April 28, 2021, during a visit to Russia. (AP Photo/Rebecca Blackwell, File)

Mexico: Russia’s Sputnik V shortages mean limited 2nd doses

Photos

This file photo of vial and syringes shows the AstraZeneca COVID-19 vaccine, on March 22, 2021. Data from a U.S. study on its vaccine shows it is 79% effective. (AP Photo/Alberto Pezzali, File)

More Photos

Quotations

AstraZeneca, which makes Evusheld, noted the FDA could reinstate its product if the share of resistant variants decreases to 90% or fewer of cases on a sustained basis.

FDA revokes emergency use of monoclonal drug, says it won't work against circulating strains →

Clapton got both AstraZeneca vaccine shots against the virus but said he had “severe reactions" and feared he'd never play again.

Eric Clapton cancels shows after testing positive for COVID-19 →

© Copyright 2023 The Washington Times, LLC
3600 New York Avenue NE, Washington, DC 20002

Switch to Desktop version